Beacon Communications Expands Aging Services Portfolio, Enters Distribution Agreement with RCare Nurse Call Technologies

Published on:

ENGLEWOOD, Colo., July 10, 2018 /PRNewswire/ -- Beacon Communications, a leader in full-service, crucial communications in healthcare for over 20 years, announced today a strategic distribution relationship with industry-leading wireless nurse call and advanced monitoring technology, RCare. As an approved RCare Trusted Integration expert, Beacon will add-on RCare's full suite of comprehensive nurse call and monitoring solutions to new and existing long-term care clients in Montana, Wyoming, and Nebraska.

"Over the past 20 years, we've been able to meet and exceed the expectations of our tremendous client base thanks to our exceptional staff, premium customer service, and by leveraging our enhanced capabilities through our business partners", says Jonathan Hasserd, VP of Sales and Marketing of Beacon Communications. "With the addition of the RCare products, we've significantly improved our ability to individualize communication systems for our clients, keeping us at the forefront of healthcare and communication technology."

In addition to RCare's advanced nurse call and monitoring solutions, Beacon provides a wide range of communication systems including security, audio/visual, access control, HVAC and more to Education, Government, Business, and Healthcare clients.

"We not only promise the best and most comprehensive wireless nurse call and monitoring technologies, but we also insist on premium installation, support and customer experience," said Myron Kowal, RCare's founder and CEO. "Beacon is a perfect fit for our Trusted Integrator program, with their proven track record in healthcare technologies and top-notch customer support."

For more information, visit www.beaconcom.com or call 303-750-6500.

Media contact:
Meagan Baalman Wairama 
198220@email4pr.com 
720-382-6695

 

SOURCE Beacon Communications

 

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.